Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with schizophrenia spectrum disorders, according to a study published in JAMA ...

The highest priority should be adults with BMI over 35 or those with BMI over 30, who also have severe obesity-related ...

Paul Edison, MD, PhD, of Imperial College London, who wasn't involved with the studies, called the findings "an undeniable ...

The authors conclude that early use of semaglutide may serve as an effective adjunctive strategy to mitigate the metabolic ...

Here are 5 things health experts say to expect after you stop taking GLP-1 drugs, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound).

Plainsboro: Novo Nordisk has announced the submission of a sNDA to the U.S. Food and Drug Administration (FDA) for a higher ...

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

Novo Nordisk is filing its supplemental new drug application (sNDA) for Wegovy 7.2 mg on the back of the phase 3b STEP UP ...

As pharmaceutical companies rapidly expand direct-to-consumer (DTC) models amid shifting US drug pricing reforms and the upcoming launch of TrumpRx, experts warn that these approaches introduce as ...

Delaware-Based Telehealth Platform Reports Increased Patient Interest in Cash-Pay Compounded Semaglutide and Tirzepatide Programs as Thanksgiving Week Signals Start of Annual Weight Loss Planning ...

Novo Nordisk A/S remains a Strong Buy despite semaglutide's Alzheimer's trial miss. Click for NVO growth drivers, solid ...

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...